In the treatment of MS, interferon beta (IFNβ) is a commonly used disease-modifying therapy (DMT) that reduces the incidence of attacks and inflammation on neural tissue by modulating the immune system. The gene discussed is IFNB1; the disease is myeloid sarcoma.